A Mussel Adhesive Protein Fused with the BC Domain of Protein A Is a Functional Linker Material That Efficiently Immobilizes Antibodies Onto Diverse Surfaces

Wednesday, October 19, 2011
Exhibit Hall B (Minneapolis Convention Center)
Chang Sup Kim1, Yoo Seong Choi2 and Hyung Joon Cha1, (1)Department of Chemical Engineering, Pohang University of Science and Technology, Pohang, South Korea, (2)Department of Chemical Engineering, Chungnam National University, Daejeon, South Korea

The efficient immobilization of antibodies onto solid surfaces is a vital factor for the sensitivity and specificity of various immunoassays and immunosensors. In the present work, we designed and produced a novel linker protein, BC-MAP, in Escherichia coli by genetically fusing mussel adhesive protein (MAP) with two domains (B and C) of protein A (antibody binding protein) for efficient antibody immobilization on diverse surfaces. Through direct surface coating analyses, we found that BC-MAP successfully coated diverse surfaces including glass, polymers, and metals, but the BC domain alone did not. Importantly, antibodies were efficiently immobilized on BC-MAP-coated surfaces, and the immobilized antibodies interacted selectively with their corresponding antigen. Quartz crystal microbalance analyses showed that BC-MAP has excellent antibody-binding ability compared to BC protein on gold surfaces. These results demonstrate that the MAP domain, with uniquely strong underwater adhesive properties, plays a role in the direct and efficient coating of BC-MAP molecules onto diverse surfaces lacking any additional surface treatment, and the BC domain of BC-MAP contributes to the selective and oriented immobilization of antibodies on BC-MAP-coated surfaces. Thus, our BC-MAP fusion protein could be a valuable novel linker material for the facile and efficient immobilization of antibodies onto diverse solid supports.

Extended Abstract: File Not Uploaded
See more of this Session: Poster Session: Bioengineering
See more of this Group/Topical: Food, Pharmaceutical & Bioengineering Division